An English study finds a reduced risk of cervical cancer recurrence following HPV vaccination following surgery, although further research is needed to confirm this finding.
Precancerous lesions correspond to changes in the cells of the epithelium of the cervix, in other words the tissue that covers it. These lesions have the particularity of being able to develop into cancer. It is not always necessary to treat a precancerous lesion. Depending on its severity, two options are possible as explained the National Institute once morest Cancer (Inca) : monitor the lesion until it heals spontaneously (which happens most often) or remove it. When the lesion must be treated, the choice of treatment must take into account the patient’s desire for pregnancy. Whatever treatment is performed, the goal is to remove the abnormal cells to prevent the lesions from progressing to cancer. In this field, a study has just shown that giving women the vaccine once morest the human papillomavirus (HPV) when precancerous lesions are removed from the cervix can reduce the risk of cell recurrence and cancer of the cervix. cervix. The study by researchers from Imperial College London published in le British Medical Journal thus suggests the vaccine might have a second key role in the fight once morest cervical cancer.
So giving a dose to women when they’re having surgery to remove precancerous cells might…
